Composition for a topical cream for curtailing bleeding and treating skin disorders
US4331653A · kind A · utility
Inventors
Key dates
| Filing date | May 11, 1979 |
| Grant date | May 25, 1982 |
| Priority date | — |
| Expiry date | May 11, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved styptic composition which effectively curtails bleeding while administering a soothing sensation on the injured area. The styptic composition is in the form of a stable lotion or cream having the following general formula: PA0 (1) from about 2% to about 12% by weight of a long chain fatty acid; PA0 (2) from about 0.4% to about 3.5% by weight of a wax filler; PA0 (3) from about 1% to about 10% by weight of polyethylene glycol stearate; PA0 (4) from about 1% to about 5% by weight of polyethylene glycol sorbitan beeswax; and, PA0 (5) from about 0.5% to about 25% by weight of an acidic metallic salt, PA0 (6) the balance being water. Optionally, from about 1% to about 4% by weight of glycerin may be added as a humectant. Any conventional antiseptic may also be added to the composition. The styptic composition may be packaged in any convenient form including jars, bottles, tubes, pump applicators, aerosol canisters and can also be impregnated into pre-packaged bandages. The composition has been found useful in the treatment of certain skin disorders such as I and D of cystic acne lesions, chicken pox, seborrhea, bleeding contact dermatitis, hemorrhoids, chapped lips, and the …
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.